Literature DB >> 21306899

Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer.

Iman Haroun1, Tracy Graham, Aletta Poll, Ping Sun, Kimberley Hill, Eleanor Weitzner, Steven Narod, Ellen Warner.   

Abstract

OBJECTIVE: To determine the reasons that motivate women in a cohort of women under intensive surveillance for breast cancer to undergo risk-reducing mastectomy (RRM). PATIENTS AND METHODS: Women with a BRCA1 or BRCA2 mutation who were enrolled in an MRI-based breast screening study were eligible to participate in this survey. A self-administered questionnaire was given to women who did, and who did not terminate annual MRI-based surveillance in order to undergo RRM. The questionnaire included information on family history, risk perception and satisfaction with screening. In addition, women were asked to provide the principal reason for their choice of having preventive surgery or not, and were asked about their satisfaction with this choice.
RESULTS: 246 women without breast cancer participated in the study. Of these, 39 women (16%) elected to have RRM at some point after initiating screening. Although women who had a mother or sister with breast cancer were more likely to opt for RRM than were women with no affected first-degree relative (21% versus 10%) this did not reach statistical significance. Women who perceived their breast cancer risk to be greater than 50% were more likely to opt for RRM than were women who estimated their risk to be less than 50% (19% versus 6%). Fear of cancer was the most common reason cited for choosing to have RRM (38% of respondents) followed by having had a previous cancer, (25%), then concern over their children (16%).
CONCLUSION: Among women with a BRCA mutation who are enrolled in an MRI-based screening program, a high perception of personal breast cancer risk and a history of breast cancer in a first-degree relative are predictors of the decision to have RRM.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21306899     DOI: 10.1016/j.breast.2011.01.006

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  11 in total

1.  Online tool to guide decisions for BRCA1/2 mutation carriers.

Authors:  Allison W Kurian; Diego F Munoz; Peter Rust; Elizabeth A Schackmann; Michael Smith; Lauren Clarke; Meredith A Mills; Sylvia K Plevritis
Journal:  J Clin Oncol       Date:  2012-01-09       Impact factor: 44.544

2.  Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial.

Authors:  Stephanie Archer; Nichola Fennell; Ellen Colvin; Rozelle Laquindanum; Meredith Mills; Romy Dennis; Francisca Stutzin Donoso; Rochelle Gold; Alice Fan; Kate Downes; James Ford; Antonis C Antoniou; Allison W Kurian; D Gareth Evans; Marc Tischkowitz
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

3.  BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families.

Authors:  Ahmed M Elnour; Abozer Y Elderdery; Jeremy Mills; Babiker A Mohammed; Daw Elbietabdelaal; Abdelraheem Osman Mohamed; Kamal Eldin H Elhassan; Abdel Hady A; Abdel Wahab; Alan Cooper
Journal:  Int J Health Sci (Qassim)       Date:  2012-01

4.  Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.

Authors:  Elizabeth Gilbert; Emily C Zabor; Michelle Stempel; Debra Mangino; Alexandra Heerdt; Melissa Pilewskie
Journal:  Ann Surg Oncol       Date:  2017-08-01       Impact factor: 5.344

Review 5.  Nipple-sparing mastectomy in women at high risk of developing breast cancer.

Authors:  Rebecca S Lewis; Angela George; Jennifer E Rusby
Journal:  Gland Surg       Date:  2018-06

6.  Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers.

Authors:  Kristin E Rojas; Elizabeth Butler; Julie Gutierrez; Rebecca Kwait; Jessica Laprise; Jennifer Scalia Wilbur; Sarah Spinette; Christina A Raker; Katina Robison; Robert Legare; Jennifer Gass; Ashley Stuckey
Journal:  Gland Surg       Date:  2019-06

Review 7.  Genomic screening of the general adult population: key concepts for assessing net benefit with systematic evidence reviews.

Authors:  Anya E R Prince; Jonathan S Berg; James P Evans; Daniel E Jonas; Gail Henderson
Journal:  Genet Med       Date:  2014-09-18       Impact factor: 8.822

Review 8.  Decision making for breast cancer prevention among women at elevated risk.

Authors:  Tasleem J Padamsee; Celia E Wills; Lisa D Yee; Electra D Paskett
Journal:  Breast Cancer Res       Date:  2017-03-24       Impact factor: 6.466

9.  Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.

Authors:  Sukh Makhnoon; Grace Tran; Brooke Levin; Kristin D Mattie; Brian Dreyer; Robert J Volk; Generosa Grana; Banu K Arun; Susan K Peterson
Journal:  Cancer       Date:  2021-06-22       Impact factor: 6.860

10.  The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Authors:  Louisa L Lo; Ian M Collins; Mathias Bressel; Phyllis Butow; Jon Emery; Louise Keogh; Prue Weideman; Emma Steel; John L Hopper; Alison H Trainer; Gregory B Mann; Adrian Bickerstaffe; Antonis C Antoniou; Jack Cuzick; Kelly-Anne Phillips
Journal:  JMIR Form Res       Date:  2018-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.